Rx Pak Division of McKesson Docusate Sodium, 100mg softgels recall — FDA D-1007-2019
Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.
Overview of recall records associated with Rx Pak Division of McKesson Corporation, including dates, categories and classifications where available.
Classification mix: Class II: 1.
Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.
This page summarizes recall records in which the official source identifies Rx Pak Division of McKesson Corporation as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.